2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Polycystic Ovary Syndrome
35
Insulin Resistance
6
Infertility
6
Hyperandrogenism
3
Anovulation
3
Pre-Eclampsia
2
Metabolic Syndrome
2
Infertility, Female
2
Glucose Intolerance
2
Diabetes, Gestational
2
Carcinoma, Non-Small-Cell Lung
2
Weight Loss
1
Thyroid Nodule
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Premature Birth
1
Precancerous Conditions
1
Periodontitis
1
Oligomenorrhea
1
Menstruation Disturbances
1
Lung Neoplasms
1
Inflammation
1
Hodgkin Disease
1
Colonic Neoplasms
1
Amenorrhea
1
Interventions
Cyclophosphamide
193
fludarabine phosphate
123
Peripheral Blood Stem Cell Transplantation
107
Etoposide
106
Mycophenolic Acid
95
Filgrastim
92
Doxorubicin
85
Whole-Body Irradiation
84
Tacrolimus
81
Brentuximab Vedotin
80
Melphalan
78
Busulfan
75
Radiotherapy
74
fludarabine
68
Cyclosporine
67
Vinblastine
65
Rituximab
60
Dacarbazine
56
Granulocyte Colony-Stimulating Factor
53
Gemcitabine
52
Antilymphocyte Serum
51
Bleomycin
50
Nivolumab
47
Methotrexate
47
Vincristine
46
Prednisone
45
Cytarabine
44
pembrolizumab
36
Carmustine
36
Bendamustine Hydrochloride
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Inositol
×
Clear all
NCT05410314
2022-06-08
Linf-inositol
University of Bari Aldo Moro
Completed
90 enrolled